
Data and Quality Initiatives: Addressing a Costly and Deadly Condition
Recorded On: 06/23/2021
Webinar Description:
This panel discussion reviews assay biological pathways, sepsis progression, and immune system collapse. It will explore the role of molecular diagnostics in sepsis workflow and how to implement effective sepsis protocols in the lab and hospital practice. Learn about the impact of COVID-19 and viral sepsis on new technology development. Clinical, policy, legislative, and regulatory perspectives and new developments in that space will be shared.
This course was originally recorded in June 2021 as part of Sepsis Tech & Innovation.
Target Audience:
Industry leaders, Public Policy Experts, Health and hospital Leadership (C-Suite, physicians, nurses, pharmacists, CIOs), Health quality and decision support leaders, Health Investors and VCs, Health and Technology Media, Health Advocates, Health Advisors, Health Educators, Health Marketers.

Hallie Prescott, MD, MSc
Associate Professor of Internal Medicine Division of Pulmonary Critical Care
University of Michigan
Hallie Prescott, MD, MSc, is an Associate Professor of Internal Medicine in the Division of Pulmonary Critical Care within Michigan Medicine and a Staff Physician at the Ann Arbor Veterans Affairs Medical Center. She is the physician lead on the HMS Sepsis and Mi-COVID19 Initiatives. Hallie completed medical school, residency, and chief residency at Ohio State University, and fellowship and Masters in Health Services Research at the University of Michigan. She is interested in sepsis, performance measurement, and long-term outcomes after critical illness. She serves as Vice-Chair of the Surviving Sepsis Campaign Guidelines, as a council member of the International Sepsis Forum, and on the advisory board of Sepsis Alliance.

Amy McKenzie, MD, MBA
Vice President, Clinical Partnerships and Associate CMO
Blue Cross Blue Shield of Michigan
Amy McKenzie, MD, MBA is a board-certified family medicine physician with 13 years of experience in private practice and over ten years of experience in healthcare administration and clinical leadership. Dr. McKenzie joined Blue Cross Blue Shield of Michigan in 2013 as a physician consultant supporting Quality Management and Accreditation and is now the Associate Chief Medical Officer and Vice President leading Clinical Partnerships. Her team is responsible for providing clinical leadership for provider value-based programs and risk contracting and helps to enable and support the network through education, communication, and partnering on practice transformation efforts. She also leads the Behavioral Health Strategy and Planning team responsible for development and implementation of the BH strategy. Dr. McKenzie graduated from Northeast Ohio Medical University and completed her residency at Ascension Providence Hospital in Southfield, Michigan. In 2017, she received her MBA with a focus in medical management from the University of Massachusetts Amherst. She is currently serving as Vice Chair on the State of Michigan Certificate of Need Commission and is a past president on the Family Medicine Foundation of Michigan.

John Syrjamaki, MPH
Manager, Data Analytics, Department of Surgery
University of Michigan
John Syrjamaki is the Manager of Data Analytics for the Michigan Value Collaborative (MVC) and a member of the Department of Surgery at the University of Michigan. After graduating from Michigan State University with a Bachelor of Science in Physiology, Mr. Syrjamaki earned a Master of Public Health in Environmental Health Sciences and Toxicology from the University of Michigan. He is responsible for leading all analytic and data-related efforts of the Collaborative, including the creation of custom performance reports and management of the online MVC data platform. He provides direct analytic consulting services to 87 member hospitals and 40 physician organizations, manages partnerships with other Blue Cross Blue Shield of Michigan (BCBSM) Collaborative Quality Initiatives (CQIs), and works closely with BCBSM and outside vendors concerning data needs and improvements.

Scott Flanders, MD
Chief Clinical Strategy Officer
Michigan Medicine
Scott A. Flanders, MD, is currently Chief Clinical Strategy Officer for Michigan Medicine, where in partnership with the Chief Strategy Officer, he leads the Department of Strategy and is responsible for the organization’s clinical growth strategy and for developing and operationalizing Michigan Medicine’s growing statewide network. Dr. Flanders is a Professor of Medicine in the Division of Hospital Medicine at the University of Michigan, where he serves as Vice Chair for the Department of Internal Medicine. He was the founding leader of Michigan’s Hospital Medicine Program, and from 2003-2017 grew the program from four faculty to over 100, while concurrently developing robust clinical, educational, quality and research programs within the section.
Dr. Flanders was a founding member of the Board of Directors of the Society of Hospital Medicine (SHM) and is a Past-President of SHM. In 2013, Dr. Flanders was awarded the designation of Master in Hospital Medicine by the Society of Hospital Medicine.
Dr. Flanders’ research interests include hospitalists, hospital-acquired conditions and their prevention, dissemination of patient safety and quality improvement practices, and the diagnosis and treatment of lower respiratory infections. Dr. Flanders developed and leads the Michigan Hospital Medicine Safety (HMS) Consortium, focused on preventing adverse events in hospitalized patients. He has authored over 200 journal articles and book chapters and has edited two textbooks and a book series in the field of Hospital Medicine. Dr. Flanders received his Medical Degree from the University of Chicago Pritzker School of Medicine and completed his residency and chief residency at the University of California, San Francisco.